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Abstract
Background: Cholera poses a substantial health burden to developing countries such as Bangladesh. In this study,
the objective is to estimate the economic burden of cholera treatments incurred by households. The study was
carried out in the context of a large vaccine trial in an urban area of Bangladesh.
Methods: The study used a combination of prospective and retrospective incidence-based cost analyses of cholera
illness per episode per household. A total of 394 confirmed cholera hospitalized cases were identified and treated in
the study area during June–October 2011. Households with cholera patients were interviewed within 15 days after
discharge from hospitals or clinics. To estimate the total cost of cholera illness a structured questionnaire was used,
which included questions on direct medical costs, non-medical costs, and the indirect costs of patients and caregivers.
Results: The average total household cost of treatment for an episode of cholera was US$30.40. Total direct and
indirect costs constituted 24.6% (US$7.40) and 75.4% (US$23.00) of the average total cost, respectively. The cost for
children under 5 years of age (US$21.50) was higher than that of children aged 5–14 years (US$17.50). The direct cost
of treatment was similar for male and female patients, but the indirect cost was higher for males.
Conclusion: Our study suggests that by preventing one cholera episode (3 days on an average), we can avert a total
cost of 2,278.50 BDT (US$30.40) per household. Among medical components, medicines are the largest cost driver. No
clear socioeconomic gradient emerged from our study, but limited demographic patterns were observed in the cost
of illness. By preventing cholera cases, large production losses can be reduced.
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Background
Cholera presents a substantial health burden in the de-
veloping world and is endemic in Africa and Asia, and
has recently spread to the Americas. An estimated 1.4
billion people worldwide are at risk of cholera; India and
Bangladesh jointly constitute the largest share of this
population [1]. Cholera is a waterborne disease and is
closely linked to inadequate environmental management.
It is responsible for 100,000–120,000 deaths per annum
globally, which constitutes an estimated 3–5 million chol-
era cases every year [2]. However, the World Health
Organization (WHO) acknowledges that only 5%–10% of
cholera cases are actually reported and it is likely that
their data on cholera rates are a gross underestimation of
the real burden of the disease [1]. In Bangladesh, there is
no accurate data on the actual number of cholera cases
but estimates by experts suggest an incidence of approxi-
mately 450,000 cases each year [3,4].
Cholera cases have increased in Bangladesh, especially
in urban settings such as in the capital of Dhaka, where
the number of hospitalized patients with more severe
cases has significantly increased [5]. Looking at diarrheal
epidemics in Dhaka in 1998, 2004, and 2007, it is appar-
ent that the number of cases of severe dehydration due
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to cholera is increasing with each epidemic: 22% in 1998,
25% in 2003, and 35% in 2007 [5,6]. Although cholera is
one of the most prevalent diseases in the country, studies
on its economic impact are limited. The Diseases of the
Most Impoverished (DOMI), a cholera cost study
group, carried out a multi-country cost-of-illness study
in Matlab (rural Bangladesh), Beira (urban neighbor-
hood in Mozambique), Kolkata (middle-class and slum
neighborhood in India), and North-Jakarta (middle-
class and slum neighborhood in Indonesia). While
DOMI studied the cost of illness in the rural context in
Bangladesh, it did not include any information regard-
ing urban Bangladesh. This current study, therefore,
aims to calculate the cost of illness for households due
to cholera treatment in an urban area with high cholera
prevalence. By addressing the information gap on the
cost of illness for households in urban Bangladesh due
to cholera treatment, this study offers a more complete
economic perspective of the cost of cholera for health
policy making in general and for prevention strategies
in Bangladesh.
Methods
Study site and population
The “Introduction of Cholera Vaccine in Bangladesh”
(ICVB) project is currently being conducted in six wards
(lowest administrative units) in Mirpur (an urban area),
Dhaka, Bangladesh. The Mirpur area is densely populated
(approximately 2.5 million people) with a high proportion
of high-risk populations prone to cholera and other diar-
rheal diseases. The wards in Mirpur were selected based
on reports of a higher influx of diarrheal patients to
Dhaka hospital of International Centre for Diarrheal Dis-
ease Research, Bangladesh (icddr,b), over the last 5 years.
The estimated rate of hospitalization due to cholera is 2–
6 per 1,000 people in these selected wards [5]. Patients of
all ages residing in Mirpur’s six wards who were con-
firmed by stool culture to have V. cholerae O1 and hospi-
talized for diarrhea were eligible to participate in this
study. It is worth noting that non-hospitalized patients
were not included because there is no scope for cholera
confirmation without laboratory testing.
Study perspective
An incidence-based approach was applied to estimate
the cost of illness of cholera treatment per episode from
a household perspective. In the study, household mem-
bers in the ICVB surveillance area who sought care at
any health facilities and were laboratory confirmed as
cholera cases by icddr,b hospitals were included. A
structured questionnaire was developed to collect data
on all possible cost components, including direct med-
ical and non-medical costs as well as indirect costs in-
curred by the households.
Sample size
All confirmed cholera hospitalized cases, coming from
one of the six wards in Mirpur during June–October
2011, were included in the study. A total of 394 con-
firmed cholera cases were identified and interviewed.
Patient enrollment
Information (name, address, cell phone number) on con-
firmed cholera patients was collected from health facility
databases and interviews were conducted within 15 days
after discharge from hospital. We interviewed the house-
hold head or the person who was most familiar with the
costs incurred during the cholera treatment of the patient.
The interviews were conducted at the respondent’s resi-
dence. Written informed consent was obtained from all re-
spondents. Structured questionnaires with both open-ended
and closed questions were used [see Additional file 1] by
trained data collectors to obtain data.
Measuring household costs of cholera
Household costs of cholera episodes include out-of-pocket
payments made by the households for the treatment of
cholera and the opportunity costs for time used by the pa-
tients and/or caregivers during the entire cholera episode.
Out-of-pocket payments consisted of direct medical and
non-medical costs. Direct medical costs included hospital
outpatient fees, admission or registration fees, physician
fees, consultant fees, payments to paramedics during home
visits for intravenous infusions, medicine costs, oral rehy-
drating solution, laboratory tests, diagnostic fees, and any
other associated medical supplies. The direct non-medical
costs include transportation, lodging, food items, tips (in-
formal payment), payment to caregiver for loss of regular
work or payment for attending patient, expenditure for ma-
terials such as utensils and other items such as mosquito
coils and lighters for patients and also the cost of caregivers
during the treatment.
Indirect costs were those related to income or productiv-
ity loss and were measured by applying the human capital
approach. Income loss for paid workers was measured by
multiplying the number of lost working hours due to a
cholera episode with the actual wage rate of the patient.
Self-reported wage rates have been used in this study. The
productivity loss due to forgone non-market activities in-
cluding school, household chores, childcare, and leisure
time were captured. The value of daily productivity was
measured on the basis of either an assumed age-specific
wage or an occupation-specific wage as used in other stu-
dies [7]. Few studies monetized the loss associated with
children [8] who have been considered to make important
economic contributions to the household [9]. We assumed
age-specific wages for three groups: adults, teenagers, and
children aged 5 to 14 years. The average daily wages of the
patients were used for adult patients, while one half and
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three-quarters of that wage were applied to teenagers and
children, respectively. Half the average wage was assigned
to unpaid home workers, taking their age group into con-
sideration [7].
Intangible costs, i.e., costs related to suffering and grief,
have been included as an additional cost category in other
studies. However, such costs are not generally valued and
no tangible economic impact is implied [9]. In this study,
the intangible cost due to cholera was not considered.
Data analysis
Data were entered into Microsoft Excel 2007. All entries
were manually double-checked and verified by the inves-
tigators. Subsequently, statistical analysis was performed
using STATA-11.1. An equivalence scale was applied to
adjust for household size when calculating household in-
come per equivalent adult [10]. Data were presented as a
total and as an average with a standard deviation in local
currency, i.e., Bangladeshi Taka (BDT) and US dollars
(US$) applying the exchange rate (US$1 = 75 BDT) dur-
ing the mid-point of the data collection year (2011).
A sensitivity analysis was conducted on direct and in-
direct costs to test the robustness of the assumptions
and to examine the impact of potential outliers in the
database [11]. Costs of informal caregivers had a higher
level of uncertainty and could be different [12]. We
tested the effects of a change of 20% in the parameters
of both direct costs and indirect costs as performed in
an earlier study [11].
Ethical approval
The research protocol of this study was approved by the
Institutional Review Board of the icddr,b.
Results
A total of 394 patients participated in the study, of
which 53% were male and 47% were female, and 36%
were younger than 5 years of age. All households that
were approached to participate in the survey gave writ-
ten consent, thus, no household refused to partake.
The average total cost of treating one episode of cholera
was found to be 2278.50 BDT (US$30.40). The direct cost
was 559.50 BDT (US$7.40), which represented 24.6% of
the total cost. Direct costs made up 24.6% of the average
total cost, of which 8.9% and 15.6% were medical and
non-medical cost components, respectively. Medicine
costs made up the largest share among all direct medical
cost components, followed by registration or admission
fees (Table 1). Among the direct non-medical cost compo-
nents, transportation constituted the largest (140 BDT or
US$1.90) followed by caregiver costs (113.25 BDT or US
$1.50). Food items (63 BDT or US$0.80) represented a
significant proportion of direct non-medical cost as well.
A wide range in cost per episode was observed in the
standard deviation from the average value. For a better
understanding of such a spread in cost, the median, and
the 5th and 95th percentiles were calculated for each cost
item. The median of the total cost was 1,306.50 BDT (US
$17.40) and the distribution as 5th and 95th percentiles
was 285 BDT (US$3.80) and 5,822 BDT (US$77.60), re-
spectively. Median direct and indirect costs were 392.50
BDT (US$5.20) and 807.50 BDT (US$10.80), respectively.
The 5th and 95th percentiles for direct costs were 80
BDT (US$1.10) and 1,430 BDT (US$19.10) and the corre-
sponding values for indirect costs were 95.60 BDT (US
$1.30) and 3,774 BDT (US$50.30), respectively.
Indirect costs were 1,719 BDT (US$23) per episode
per household, which represented 75.4% of the average
total cost (Table 1). We also observed that the average
caregiver’s production loss (908 BDT or US$12.20) was
higher than that of the patient’s (811 BDT or US$11).
A one-way sensitivity analysis with a 20% increase in
the parameters of direct and indirect costs showed that
the total cost increased by 4.9% and 15%, respectively.
Costs across income groups
The average total cost of the poorest (1st) quintile was
1,894.50 BDT (US$25.30) while that of the richest was
2,335.60 BDT (US$31.10) per episode. Households in the
second quintile incurred the largest average total cost
(2,993 BDT or US$40). No socioeconomic gradient was ob-
served. Direct costs represented approximately 29% of total
cost in the poorest, middle, and richest quintiles. The cor-
responding shares in the second and fourth quintiles were
15.5% and 23.3%, respectively (see Table 2).
Costs across age groups
The average total costs ranged between 1,314 BDT (US
$17.50) and 6,214 BDT (US$82.60). The largest cost was
observed among patients aged 60 years and older. The
direct costs ranged between 345 BDT (US$4.60) and 635
BDT (US$8.50) and the highest cost was observed among
patients under 5 years of age. While indirect costs in-
creased for older patients, the direct costs did not show
significant disparity across age groups (see Table 3).
Costs by gender
The average total costs for males and females were BDT
2,526 (US$33.80) and BDT 1,995 (US$26.50), respectively.
The average direct costs were slightly more for males than
females. The difference in average total cost can be ex-
plained by associated indirect costs, as a greater number
of males are in the labor market. We found that the differ-
ence in indirect costs was higher for males (see Table 4).
Among children under 5 years of age, males have a
higher average total cost (1,763.40 BDT or US
$23.50) than females (1,321.40 BDT or US$17.70).
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Both direct and indirect costs were higher for male
children (see Table 5).
Discussion
This study found that both the average and median
length of a cholera episode was 3 days and the 5th and
9th percentiles of the episode were 1 and 6 days, re-
spectively. This costing study was carried out in the
Mirpur area of Dhaka, in which vaccination trial was
also carried out. In the target area, 123,661 people had
received their full vaccinations. However, in our current
study sample, only 84 of 394 were fully vaccinated. The
data for this study were collected when the vaccine trial
had just started and the effect of vaccination may not
have been achieved that time.
While the cost of illness for cholera in rural Bangladesh
had been investigated in an earlier study, such information
was lacking for urban areas in the country. In a multi-
country study, previous researchers applied hospital-based
data collection techniques in rural Bangladesh to estimate
the cost of illness due to endemic cholera [7]. That study
also included India, Mozambique, and Indonesia. It was
found that the average cost of illness for a Bangladeshi
household was US$12.40. The corresponding costs in
Beria (Mozambique), Kolkata (India), and North Jakarta
(Indonesia) were US$18.80, US$17.90, and US$134.00, re-
spectively [7]. The current study, however, found that the
average total cost per episode of cholera illness for house-
holds is BDT 2,278.50 (US$30.40).
Medicine, transportation, caregiver costs, and oppor-
tunity costs (indirect costs) were the largest cost compo-
nents in the study. Some of the costs varied across
socioeconomic and demographic groups.
The total indirect cost was more than three times
higher than the total direct cost. Among the direct costs,
medical related costs constituted 36.4% of the total,
Table 1 Average household cost of cholera treatment, BDT (US$*)
Costs Parameters Average cost Standard deviation Proportion of total cost
Direct Medical Diagnostic 9.6 (0.1) 75.7 (1)
9
Medicine 148.7 (2) 246 (3.)
Registration fee 26.1 (0.3) 130.6 (1.7)
Paramedics home visit fee 2.8 (−) 21.5 (0.3)
Bed/ Cabin charge 16.9 (0.2) 130.7 (1.7)
Direct Non-Medical Transportation cost 140 (1.9) 122 (1.6)
15.6
food items 63(0.8) 85 (1.1)
Informal payment 0.7 (−) 9 (0.1)
Caregivers payment 0.1 (−) 1 (−)
Materials (mug/glass/coil etc.) 10.6(0.1) 17 (0.2)
Lodging 28 (0.4) 101 (1.3)
Caregivers expenditure 113.2 (1.5) 172 (2.3)
Total direct cost 559.5 (7.4) 641.7 (8.5) 24.6
In-direct Patients income loss 811 (11) 4,301 (57)
Caregivers income loss 908 (12.2) 3,701 (49)
Total indirect cost 1,719 (23) 5,656 (75.4) 75.4
Total cost of illness of household 2,278.5 (30.4) 5,668 (75.6) 100
*1 US dollar (US$) = 75 Bangladeshi Taka (BDT) in mid 2011.
Table 2 Household average cost of cholera treatment by












1 (≤1647) 82 562 (7.5) 1,332.5 (17.8) 1,894.5 (25.3)
2 (1,648-2,500) 78 474 (6.3) 2,519 (33.6) 2,993 (39.9)
3 (2,501-3,529) 80 482.9 (6.4) 1,197 (16) 1,680 (22.4)
4 (3,530 -5,333) 83 583.4 (7.8) 1,927 (25.7) 2,510.4 (33.5)
5 (5,334+) 77 696.4 (9.3) 1,639.2 (22) 2,335.6 (31.1)
Table 3 Household average cost of cholera treatment by











Up to 4 131 635 (8.5) 980 (13) 1,615 (21.5)
5 to 14 34 537 (7) 778 (10) 1,314 (17.5)
15 to 45 178 529 (7) 1,733 (23) 2,261 (30)
46 to 60 39 532 (7) 3,682 (49) 4,214 (56.2)
60+ 12 345 (4.6) 5,870 (78) 6,214 (82.6)
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representing the largest share. Among the non-
medical components, transportation costs were the
highest, followed by caregiver costs, which included
food, lodging, and cell phone costs. It was found that
the average total cost of illness was greater for adult
patients than child patients (Table 3). The variation in
average total costs across age groups can be explained
by indirect costs because the direct costs do not differ
greatly across groups. While the indirect costs of
adult patients can be influenced by their wage level
and length of cholera episode, such costs for children
are also influenced by these factors (wage and length
of episode) in terms of their caregiver. The data from
this study show that the health-seeking behavior of
adults and children differs to some extent. For in-
stance, children are often taken to local private practi-
tioners before hospitalization, while adult patients
generally seek care directly from hospitals. A disag-
gregation of costs into components provides a better
understanding of the cost drivers. In the two icddr,b
hospitals (Dhaka and Mirpur hospitals), all diagnostic
tests and medicines were provided free of charge
to the patients. Although the patients received their
required medicine in hospital, some patients still pur-
chased extra medicine from nearby pharmacies. In
contrast, a large amount of money was spent in pri-
vate hospitals on diagnosis and medicine. In addition,
private hospitals also charged registration fees that
are not charged in icddr,b hospitals. In some cases,
out-of-pocket payments were incurred by households
(Table 1), e.g., fees for home visits from paramedics
who offer various services including intravenous sa-
line solution and providing advice.
The high costs of transportation can be explained
by travel time on highly congested roads in Dhaka.
The approximate travel time to private facilities was
60 minutes, whereas it took on average 80 and 48 mi-
nutes to reach the icddr,b Dhaka hospital and Mirpur
hospital, respectively. It was also observed that wait-
ing time in private hospitals was longer (16 minutes)
than in the icddr,b hospitals (4.2 minutes on average).
The highest waiting times (the longest was 34 mi-
nutes) were observed in private clinics and hospitals
outside the cholera surveillance area (see Table 6).
This study does have some limitations. There may
be some recall bias as data were collected after receiv-
ing treatment. However, to minimize the bias, we
conducted all interviews within 15 days of discharge
from hospital. Outpatients were excluded in this study
as no confirmed cholera outpatient cases were identified
during the data collection period. The patients enrolled in
this study were from a high-risk cholera area [8] and all
cases were hospitalized, who may have some specific
healthcare seeking behavior as the cases considered were
serious. This study did not address this issue.
Conclusions
Our study suggests that by preventing one cholera epi-
sode (3 days on an average), we can avert a total cost
of 2,278.50 BDT (US$30.40) per household. Simultan-
eously, the cost of public and not-for-profit private
providers can be reduced. This finding has implica-
tions regarding policy decisions about investment for
cholera prevention programs.
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Table 4 Cost of cholera treatment by sex
Sex Number of
patients
Average cost, BDT (US$)
Direct cost Indirect cost Total cost
Male 210 556 (7.5) 1,970 (26.3) 2,526 (33.8)
Female 184 563 (7.4) 1,432 (19.1) 1,995 (26.5)
Total 394 559 (7.4) 1,719 (23) 2,286 (30.4)
Table 5 Gender differential in average cost of cholera
treatment among under-five children
Sex Number of
patients
Average cost, BDT (US$)
Direct cost Indirect cost Total cost
Male 87 642.4 (8.6) 1,121 (15) 1,763.4 (23.5)
Female 54 564.4 (7.7) 756 (10) 1,321.4 (17.7)
Total 141 612.5 (8.2) 982 (13) 1,594.2 (21.2)











Local pharmacy 291 11.6 1.5 13.1
Local MBBS physicians 25 25.1 13.2 38.3
icddr,b Mirpur hospital 266 48.4 4.3 52.7
icddr,b Dhaka hospital 137 80 4 84
Private clinics (ten other
health facilities)2
33 56 16 72
Traditional practitioner 4 12.3 0 12.3
Other private clinic3 10 27.3 34 61.3
1)Multiple visits applied; 2)Patients frequently visit these hospitals; 3)Located
outside ICVB surveillance area.
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